Studies have shown that active fund managers routinely underperform the S&P500 index*​

Lisata Therapeutics, Inc. (NASDAQ: LSTA)

LSTA Stock Predictions and Ratings

WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-28.60%
Analyst Rating:
HOLD
Analyst Forecast (1yr):
NOT AVAILABLE

LSTA Stock Analysis

LSTA PE Ratio:

LSTA PEG Ratio: Not Available

LSTA Forward EPS Growth (12 month): 0.00%

LSTA PS Ratio: 187.2

LSTA PSG Ratio: Not Available

LSTA Forward Revenue Growth (12 month): 0.00%

LSTA Articles

No data was found